// App-Quantinova.ai

1199-96 : BAYESIAN NET-CLINICAL BENEFIT ANALYSIS OF RIVAROXABAN IN PATIENTS WITH ACUTE CORONARY SYNDROMES

Researchers

Presenter

  • Rohit Arora

Principal Investigators

  • Christopher Lang

  • Abdullah Quddus

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Acute Coronary Syndromes

  • Pulmonary embolism

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved